15670RAC1
Cepheid
Could not find a ticker for this position, may be a filing error
A maker of molecular diagnostic tests, Cepheid builds the GeneXpert system, an automated machine that quickly detects infections like tuberculosis, flu, and COVID-19 from a patient sample. Founded in 1996, the company took its name from Cepheid variable stars — pulsing "standard candles" astronomers use to measure the universe, a nod to precision. It became part of Danaher in 2016.
CONVERTIBLEUnderlying: CPHDCUSIP: 15670RAC1HealthcareUS1 derivative reporter
1.25% Convertible Senior Notes due 2021
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
